Idipharma Alternatives & Competitors
12 companies similar to Idipharma — Azienda farmaceutica specializzata in formulazione e immissione in commercio di...
Companies similar to Idipharma
LACASA-PHARMA
𝑪𝒐𝒎𝒎𝒊𝒕𝒕𝒆𝒅 𝒊𝒎𝒑𝒓𝒐𝒗𝒊𝒏𝒈 𝒕𝒉𝒆 𝒒𝒖𝒂𝒍𝒊𝒕𝒚 𝒐𝒇 𝑳𝒊𝒇𝒆….
Osteal Therapeutics
Revolutionizing the treatment of orthopedic infection. Preserving Limbs. Preserving Lives
CardioFocus
Lesion Creation at the Speed of Light
OMNI
Pioneering advanced respiratory drug delivery solutions for asthma and chronic obstructive...
Track all Idipharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Richen Europe
Pharmaceutical Company founded in 2014 as part of Richen Medical Science Group which opera...
Elite Clinical Studies, LLC
By doing research we help bring new advanced drugs to market that enhance the quality of...
Hera Health Solutions
Redefining Drug Delivery
dianosic
"Smartly designed for you"
Imunopharm Technology
Make the incurable curable
Yaqrit
The Liver Disease Company
Innoture
Improve patient and public health with our next-generation microneedle technology
About Idipharma
Idipharma is an Italian pharmaceutical company specialized in the formulation and commercialization of innovative specialty products. Founded in 1997 by Dr. Pietro Bottino, a knowledgeable pharmacist, the company focuses on developing and bringing to market innovative products targeting the damaging effects of radical...
Pharmaceutical Research, Innovative Formulations, Antioxidant Technology, Infertility Treatment, Urological Solutions, Gynecological Innovations
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Idipharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Idipharma on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 1 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.